Examining the impact of geographic distance and social vulnerability on interstitial lung disease care and outcomes is essential, as access barriers disproportionately affect h ...

Pulmonary fibrosis—also known in technical terms as idiopathic pulmonary fibrosis (IPF)—is a rare but life-threatening ...

Pulmonary hypertension is a syndrome characterized by marked remodeling of the pulmonary vasculature and a progressive rise in the pulmonary vascular load, leading to hypertrophy and remodeling of the ...

Please provide your email address to receive an email when new articles are posted on . The FDA based sotatercept's/Winrevair’s approval on data from the phase 3 ...

Idiopathic pulmonary fibrosis (IPF) is a progressive lung disease marked by gradual scarring, limiting lung function. The exact cause is unknown, but it combines genetic and environmental factors.